Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleComment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia".AuthorsPerrotti, Danilo; Agarwal, Anupriya; Lucas, Claire M.; Narla, Goutham; Neviani, Paolo; Odero, Maria D.; Ruvolo, Peter P.; Verrills, Nicole M.AbstractLB100 does not sensitize CML stem cells to tyrosine kinase inhibitor–induced apoptosis.SubjectsCANCER stem cells; PROTEIN-tyrosine kinases; KINASE inhibitors; LEUKEMIA; STEM cellsPublicationScience Translational Medicine, 2019, Vol 11, Issue 501, p1ISSN1946-6234Publication typeArticleDOI10.1126/scitranslmed.aau0416